Ekso Bionics Holdings, Inc. (EKSO) earnings

EKSO earnings moved a median of -0.57% by the close. Quarterly and annual EKSO reports and results, each read against the price at its own news timestamp. Back to the EKSO overview →

26 measured EKSO earnings events.

Where these EKSO earnings landedvs 24 measured EKSO earnings reactions
EKSO earningsMiddle 50% · -4.62% to +6.49%Zero: 0.00%Median: -0.57%Median -0.57%-10.00%0+10.00%
Middle 50% of EKSO earnings reactions-4.62% to +6.49%
Median reaction (to close)-0.57%
Measured reactions24
Point-in-time · zero look-ahead

Half of the 24 EKSO earnings events with a measured close landed between -4.62% and +6.49%; 46% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q EKSO BIONICS HOLDINGS, For: Mar 31SEC filing · Form 10-Q-3.20%-1.12%
Form 10-K/A EKSO BIONICS HOLDINGS, For: Dec 31SEC filing · Form 10-K+0.11%+7.60%
Form 10-K EKSO BIONICS HOLDINGS, For: Dec 31SEC filing · Form 10-K+1.50%-4.42%
Ekso Bionics Reports Third Quarter 2025 Financial ResultsPress release+0.00%+9.38%
Form 10-Q EKSO BIONICS HOLDINGS, For: Sep 30SEC filing · Form 10-Q+0.00%+9.38%
Ekso Bionics Reports Second Quarter 2025 Financial ResultsPress release+2.43%—
Form 10-Q EKSO BIONICS HOLDINGS, For: Jun 30SEC filing · Form 10-Q+2.43%—
Ekso Bionics to Report Second Quarter 2025 Financial Results on July 28 – Conference Call to FollowPress release-2.07%-5.85%
Ekso Bionics Reports First Quarter 2025 Financial ResultsPress release-2.93%+6.65%
Form 10-Q EKSO BIONICS HOLDINGS, For: Mar 31SEC filing · Form 10-Q-2.93%+6.65%
Ekso Bionics to Report First Quarter 2025 Financial Results on May 5 – Conference Call to FollowPress release-2.03%-4.12%
Form 10-K EKSO BIONICS HOLDINGS, For: Dec 31SEC filing · Form 10-K-1.13%+1.32%
Ekso Bionics Reports Certain Preliminary Fourth Quarter 2024 Financial ResultsPress release-1.54%-8.71%
Ekso Bionics Announces Third Quarter 2024 Financial ResultsPress release+3.50%+6.29%
Form 10-Q EKSO BIONICS HOLDINGS, For: Sep 30SEC filing · Form 10-Q+3.50%+6.29%
Ekso Bionics to Report Third Quarter 2024 Financial Results on October 28, 2024Press release+0.00%-1.91%
Ekso Bionics Reports Record Quarterly Sales of $5.0 Million in Second Quarter 2024Press release-6.45%-14.52%
Form 10-Q EKSO BIONICS HOLDINGS, For: Jun 30SEC filing · Form 10-Q-6.45%-14.52%
Ekso Bionics to Report Second Quarter 2024 Financial Results on July 29, 2024Press release+0.00%+3.31%
Ekso Bionics Announces First Quarter 2024 Financial ResultsPress release-0.77%-4.62%
Form 10-Q EKSO BIONICS HOLDINGS, For: Mar 31SEC filing · Form 10-Q-0.77%-4.62%
Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024Press release+0.00%-3.03%
Form 10-K EKSO BIONICS HOLDINGS, For: Dec 31SEC filing · Form 10-K-6.86%-9.71%
Ekso Bionics Reports Third Quarter 2023 Revenue Growth of 38%Press release+0.00%+6.49%
Form 10-Q EKSO BIONICS HOLDINGS, For: Sep 30SEC filing · Form 10-Q+0.00%+6.49%
Ekso Bionics to Report Third Quarter 2023 Financial Results on October 26, 2023Press release+0.00%-0.01%
That’s how EKSO usually reacts to earnings — get an email when it moves on news →
Keep exploring

More EKSO: analyst actions → · SEC filings → · EKSO overview →

Other Healthcare names and their earnings

TickerEventsMedian 30-min% positive
Strata Skin Sciences, Inc. (SSKN)1760.00%39%
Capstone Holding Corp. (CAPS)175-2.00%35%
ReShape Lifesciences, Inc. (RSLS)175-0.61%39%
EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share (EDAP)1740.00%45%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.